Donate today and join the fight to achieve global malaria elimination targets.
Together we can make a significant contribution to achieving malaria elimination targets.
Improving the health of vulnerable communities and changing lives is at the heart of what we do and who we are.
With approximately 71 million people chronically infected worldwide and 1.75 million new infections in 2015, hepatitis C virus remains a significant public health concern. In developed countries hepatitis C transmission is predominantly driven by the sharing of injecting equipment, placing people who inject drugs (PWID) at the greatest risk of infection. It is estimated that approximately half of the PWID population are hepatitis C antibody positive. This article is protected by copyright. All rights reserved.
To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2022 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present.
We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
